Prevent concomitant utilization of tucatinib with CYP3A substrates, in which minimal focus changes might lead to major or life-threatening toxicities. If unavoidable, minimize CYP3A substrate dose In accordance with product or service labeling.Akutt og alvorlig allergisk reaksjon med symptomer som feber, utslett, opphovning, pustebesvær og blodtry… Read More